Detalhe da pesquisa
1.
Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
J Antimicrob Chemother
; 76(5): 1286-1293, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624081
2.
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Lancet HIV
; 4(9): e384-e392, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566227